
Related topics: Ingredients
URL Pharma has acquired a 19,000 sq ft facility equipped for development and manufacture of modified release products from PharmPro.
The facility includes fluid bed technology, which is used in the water and solvent coating processes that are needed in the development and manufacture of modified release products.
Furthermore, the acquisition includes DuraGran. This is a proprietary technology platform enables the production of uniform, small granules, which are also used in modified release products.
URL will also acquire the services of 17 former PharmPro employees that have critical engineering expertise. These employees, infrastructure and technology have been acquired to improve URL’s in-house capabilities.
Copyright - Unless otherwise stated all contents of this web site are © 2012 - William Reed Business Media SAS - All Rights Reserved - For permission to reproduce any contents of this web site, please email our Syndication department copyright@wrbm.com - Full details for the use of materials on this site can be found in the Terms & Conditions
© 2012 - William Reed Business Media SAS - All rights reserved. ![]()